208 related articles for article (PubMed ID: 27013160)
1. Chemical Renal Denervation: The Pursuit for Simplicity.
Waksman R
JACC Cardiovasc Interv; 2016 Mar; 9(6):599-601. PubMed ID: 27013160
[No Abstract] [Full Text] [Related]
2. Renal denervation: Should we ignore the proximal segment of renal artery?
Huang B; Zhou X; Jiang H
Int J Cardiol; 2017 Dec; 249():364. PubMed ID: 29121740
[No Abstract] [Full Text] [Related]
3. Catheter-based renal denervation in hypertension: heading for new shores.
Mahfoud F; Böhm M; Edelman ER
J Hypertens; 2018 Jan; 36(1):41-42. PubMed ID: 29210859
[No Abstract] [Full Text] [Related]
4. Hypertension: Update on renal artery denervation.
Fernández-Ruiz I
Nat Rev Cardiol; 2016 Oct; 13(10):570. PubMed ID: 27538815
[No Abstract] [Full Text] [Related]
5. Renal denervation for resistant hypertension: not dead yet.
Reddy VY; Olin JW
J Am Coll Cardiol; 2014 Sep; 64(11):1088-91. PubMed ID: 25212641
[No Abstract] [Full Text] [Related]
6. Patients with renal artery stenosis may not be suitable for renal denervation.
Wang Y
Clin Res Cardiol; 2014 Jul; 103(7):585-6. PubMed ID: 24676560
[No Abstract] [Full Text] [Related]
7. Long-Term Results up to 12 Months After Catheter-Based Alcohol-Mediated Renal Denervation for Treatment of Resistant Hypertension.
Mahfoud F; Sievert H; Bertog S; Lauder L; Ewen S; Lengelé JP; Wojakowski W; Schmieder R; van der Giet M; Weber MA; Kandzari DE; Parise H; Fischell TA; Pathak A; Persu A
Circ Cardiovasc Interv; 2021 Sep; 14(9):e010075. PubMed ID: 34470501
[TBL] [Abstract][Full Text] [Related]
8. Catheter-based Renal Denervation as a Treatment for Pulmonary Hypertension: Hope or Hype?
Santos-Gallego CG; Badimón JJ
Rev Esp Cardiol (Engl Ed); 2015 Jul; 68(7):551-3. PubMed ID: 26032026
[No Abstract] [Full Text] [Related]
9. Renal denervation for resistant hypertension: closing in on potential confounders.
Schlaich MP; Schultz C; Shetty S
J Hypertens; 2016 Aug; 34(8):1505-6. PubMed ID: 27356001
[No Abstract] [Full Text] [Related]
10. Renal sympathetic denervation for resistant hypertension in a patient with a single kidney.
Xu B; Whitbourn RJ
Med J Aust; 2014 Mar; 200(4):206-7. PubMed ID: 24580520
[No Abstract] [Full Text] [Related]
11. The future for renal denervation depends on embracing the lessons learned from our previous studies.
Epstein M
J Am Soc Hypertens; 2016 May; 10(5):396-8. PubMed ID: 27079956
[TBL] [Abstract][Full Text] [Related]
12. Safety and Clinical Outcome of the Delivery of Radiofrequency Nerve Ablation Therapy in a Renal Artery of Unusual Anatomy.
de Leon-Martinez EP; Garza JA; Azpiri-Lopez JR; Dillon KN; Salazar LO; Canepa-Campos F; Rousselle SD; Tellez A
High Blood Press Cardiovasc Prev; 2015 Dec; 22(4):445-8. PubMed ID: 26014838
[TBL] [Abstract][Full Text] [Related]
13. Plasma renalase concentration before and after radiofrequency renal denervation in patients with resistant hypertension.
Wybraniec MT; Czerwieńska B; Lelek M; Adamczak M; Więcek A; Mizia-Stec K
J Hum Hypertens; 2016 Jun; 30(6):410-1. PubMed ID: 26310184
[No Abstract] [Full Text] [Related]
14. Renal denervation vascular effects: An "insider's" view.
Dimitriadis K; Tsioufis C
Hellenic J Cardiol; 2020; 61(3):197-198. PubMed ID: 32916295
[TBL] [Abstract][Full Text] [Related]
15. Blood Pressure Response to Main Renal Artery and Combined Main Renal Artery Plus Branch Renal Denervation in Patients With Resistant Hypertension.
Fengler K; Ewen S; Höllriegel R; Rommel KP; Kulenthiran S; Lauder L; Cremers B; Schuler G; Linke A; Böhm M; Mahfoud F; Lurz P
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862930
[TBL] [Abstract][Full Text] [Related]
16. Renal Denervation.
Hameed MA; Dasgupta I
Adv Exp Med Biol; 2017; 956():261-277. PubMed ID: 27815927
[TBL] [Abstract][Full Text] [Related]
17. Renal denervation using an irrigated radiofrequency ablation catheter for management of drug-resistant hypertension: a demonstrated value?
Frohlich ED
JACC Cardiovasc Interv; 2012 Jul; 5(7):766-8. PubMed ID: 22814782
[No Abstract] [Full Text] [Related]
18. [Renal denervation a treatment for resistant hypertension: a French experience].
Benamer H; Mylotte D; Garcia-Alonso C; Unterseeh T; Garot P; Louvard Y; Lefevre T; Morice MC;
Ann Cardiol Angeiol (Paris); 2013 Dec; 62(6):384-91. PubMed ID: 24182849
[TBL] [Abstract][Full Text] [Related]
19. Safety and performance of the second generation EnligHTN™ Renal Denervation System in patients with drug-resistant, uncontrolled hypertension.
Worthley SG; Wilkins GT; Webster MW; Montarello JK; Delacroix S; Whitbourn RJ; Warren RJ
Atherosclerosis; 2017 Jul; 262():94-100. PubMed ID: 28531827
[TBL] [Abstract][Full Text] [Related]
20. A mechanistic explanation for the minimal impact of renal denervation on 24-h ambulatory blood pressure in SIMPLICITY HTN-3.
Middlekauff HR
J Am Coll Cardiol; 2015 Mar; 65(9):959. PubMed ID: 25744017
[No Abstract] [Full Text] [Related]
[Next] [New Search]
